Stock listing
NASDAQ:ARTL Artelo Biosciences, Inc. Stock
Home listing (NASDAQ) of Artelo Biosciences, Inc.
Follow Artelo Biosciences, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:ARTL
$2.22 USD -0.09 (-3.9%)
Close on Oct 30, 2026
- Day range
- $2.18 – $2.29 USDOct 30, 2026
- Volume
- 11,567 sharesOct 30, 2026
- Market cap
- $1.22M USDAt the close on Oct 30, 2026 · price × 547,774 shares outstanding
- 52-week range
- $2.10 – $179.19 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $3.11M USDMedian day 28,550 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ARTL · Home | $2.22 USD | -0.09 (-3.9%) | 11,567 | $2.25 | $2.285 | $2.18 | $2.31 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:ARTL · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.22 | -0.09 | -3.9% | $2.25 | $2.285 | $2.18 | 11,567 | |
| $2.31 | -0.02 | -0.9% | $2.365 | $2.40 | $2.25 | 53,434 | |
| $2.33 | +0.13 | +5.9% | $2.24 | $2.42 | $2.24 | 41,741 | |
| $2.20 | 0.00 | 0.0% | $2.21 | $2.277 | $2.095 | 30,470 | |
| $2.20 | -0.35 | -13.7% | $2.54 | $2.54 | $2.15 | 169,361 | |
| $2.55 | 0.00 | 0.0% | $2.64 | $2.655 | $2.48 | 26,100 | |
| $2.55 | -0.01 | -0.4% | $2.62 | $2.64 | $2.53 | 10,200 | |
| $2.56 | -0.06 | -2.3% | $2.64 | $2.71 | $2.56 | 17,400 | |
| $2.62 | -0.04 | -1.5% | $2.698 | $2.80 | $2.62 | 26,300 | |
| $2.66 | -0.04 | -1.5% | $2.83 | $2.83 | $2.66 | 16,300 | |
| $2.70 | -0.04 | -1.5% | $2.75 | $2.759 | $2.70 | 12,300 | |
| $2.74 | -0.14 | -4.9% | $2.80 | $2.90 | $2.74 | 17,600 | |
| $2.88 | -0.10 | -3.4% | $2.95 | $2.97 | $2.82 | 43,000 | |
| $2.98 | -0.13 | -4.2% | $3.11 | $3.12 | $2.92 | 30,800 | |
| $3.11 | -0.15 | -4.6% | $3.172 | $3.25 | $3.11 | 23,000 | |
| $3.26 | -0.11 | -3.3% | $3.441 | $3.45 | $3.19 | 45,500 | |
| $3.37 | -0.04 | -1.2% | $3.51 | $3.51 | $3.37 | 27,200 | |
| $3.41 | -0.05 | -1.4% | $3.42 | $3.55 | $3.33 | 49,900 | |
| $3.46 | -0.05 | -1.4% | $3.65 | $3.74 | $3.41 | 74,400 | |
| $3.51 | -0.17 | -4.6% | $3.75 | $3.75 | $3.50 | 46,900 | |
| $3.68 | -0.15 | -3.9% | $3.85 | $3.85 | $3.63 | 63,000 | |
| $3.83 | -0.21 | -5.2% | $4.04 | $4.07 | $3.80 | 92,400 | |
| $4.04 | -0.03 | -0.7% | $4.06 | $4.30 | $3.95 | 67,700 | |
| $4.07 | -0.23 | -5.3% | $4.20 | $4.30 | $4.05 | 87,000 | |
| $4.30 | -0.24 | -5.3% | $4.44 | $4.55 | $4.25 | 153,500 | |
| $4.54 | -0.63 | -12.2% | $4.93 | $4.93 | $4.43 | 256,500 | |
| $5.17 | -2.14 | -29.3% | $4.87 | $5.35 | $4.51 | 1,050,400 | |
| $7.31 | +3.16 | +76.1% | $4.03 | $15.73 | $3.90 | 25,129,700 | |
| $4.15 | +0.05 | +1.2% | $4.14 | $4.20 | $3.86 | 324,300 | |
| $4.10 | +0.16 | +4.1% | $3.89 | $4.19 | $3.882 | 71,800 | |
| $3.94 | -0.03 | -0.8% | $4.00 | $4.136 | $3.92 | 29,400 | |
| $3.97 | +0.22 | +5.9% | $3.84 | $4.02 | $3.69 | 124,800 | |
| $3.75 | -1.59 | -29.8% | $4.90 | $4.90 | $3.45 | 276,600 | |
| $5.34 | +0.47 | +9.7% | $4.88 | $5.65 | $4.88 | 89,900 | |
| $4.87 | -0.56 | -10.3% | $5.28 | $5.49 | $4.86 | 54,800 | |
| $5.43 | -0.20 | -3.6% | $5.69 | $5.84 | $5.35 | 41,000 | |
| $5.63 | -0.35 | -5.9% | $5.89 | $6.00 | $5.61 | 41,300 | |
| $5.98 | -0.21 | -3.4% | $6.415 | $6.415 | $5.98 | 29,300 | |
| $6.19 | +0.15 | +2.5% | $6.135 | $6.38 | $5.918 | 10,700 | |
| $6.04 | -0.18 | -2.9% | $6.25 | $6.345 | $5.92 | 27,800 | |
| $6.22 | -0.30 | -4.6% | $6.60 | $6.805 | $6.22 | 27,700 | |
| $6.52 | +0.365 | +5.9% | $6.10 | $6.706 | $5.991 | 43,100 | |
| $6.155 | -0.205 | -3.2% | $6.05 | $6.39 | $5.70 | 84,300 | |
| $6.36 | +0.393 | +6.6% | $5.95 | $6.79 | $5.34 | 587,500 | |
| $5.967 | +0.018 | +0.3% | $5.931 | $6.12 | $5.562 | 29,635 | |
| $5.949 | -0.45 | -7.0% | $6.102 | $6.282 | $4.68 | 10,289 | |
| $6.399 | -0.054 | -0.8% | $6.345 | $6.57 | $6.345 | 1,142 | |
| $6.453 | +0.252 | +4.1% | $6.30 | $6.462 | $6.12 | 1,751 | |
| $6.201 | -0.027 | -0.4% | $6.111 | $6.39 | $5.94 | 1,268 | |
| $6.228 | -0.18 | -2.8% | $6.48 | $6.57 | $6.12 | 1,343 | |
| $6.408 | -0.072 | -1.1% | $6.444 | $6.75 | $6.30 | 4,330 | |
| $6.48 | -0.09 | -1.4% | $6.444 | $6.75 | $6.363 | 2,475 | |
| $6.57 | +0.081 | +1.2% | $6.318 | $6.84 | $6.318 | 5,920 | |
| $6.489 | -0.621 | -8.7% | $7.092 | $7.20 | $6.21 | 80,905 | |
| $7.11 | +0.279 | +4.1% | $6.957 | $8.19 | $6.876 | 5,685 | |
| $6.831 | +0.234 | +3.5% | $6.75 | $7.56 | $6.435 | 3,277 | |
| $6.597 | -0.108 | -1.6% | $6.705 | $6.795 | $6.39 | 1,042 | |
| $6.705 | +0.36 | +5.7% | $6.48 | $6.84 | $6.48 | 1,179 | |
| $6.345 | -0.144 | -2.2% | $6.48 | $6.75 | $6.345 | 2,047 | |
| $6.489 | -0.279 | -4.1% | $6.93 | $6.93 | $6.489 | 1,446 | |
| $6.768 | +0.009 | +0.1% | $6.84 | $6.93 | $6.669 | 1,058 | |
| $6.759 | -0.126 | -1.8% | $6.93 | $7.11 | $6.759 | 1,415 | |
| $6.885 | +0.198 | +3.0% | $6.741 | $6.93 | $6.678 | 1,472 | |
| $6.687 | -0.243 | -3.5% | $6.84 | $7.191 | $6.687 | 1,590 | |
| $6.93 | +0.135 | +2.0% | $7.20 | $7.38 | $6.75 | 1,578 | |
| $6.795 | +0.288 | +4.4% | $6.84 | $7.11 | $6.57 | 4,498 |
- Ticker
- NASDAQ:ARTL
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 26, 2026
Artelo Biosciences to Showcase First-in-Human FABP5 Inhibitor ART26.12 as a Novel Approach to Pain Treatment at IASP 2026 World Congress on Pain
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 25 slides
Latest news
Artelo Biosciences to Showcase First-in-Human FABP5 Inhibitor ART26.12 as a Novel Approach to Pain Treatment at IASP 2026 World Congress on Pain
Oct 26, 2026
Closed $2.20 (-13.7%) on Oct 26, 2026
Artelo Biosciences Selected for its First-Ever Company Presentation at BIO-Europe 2026 to Showcase Clinical Progress and Expanding Potential of its Novel FABP5 Inhibitor Platform
Oct 7, 2026
Closed $3.41 (-1.4%) on Oct 7, 2026
Artelo Biosciences Files New Provisional Patent Application Covering ART27.13 for Obesity, Alone and in Combination with GLP-1 Receptor Agonists, Following Unexpected Nonclinical Findings
Sep 23, 2026
Closed $7.31 (+76.1%) on Sep 23, 2026
Artelo Biosciences Announces ART27.13 Achieved Weight Loss Comparable to Semaglutide as a Monotherapy and Doubled Weight Loss in Combination with Semaglutide in a Nonclinical Model of Obesity
Sep 16, 2026
Closed $3.75 (-29.8%) on Sep 16, 2026
Artelo Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep 8, 2026
Closed $6.19 (+2.5%) on Sep 8, 2026
Artelo Biosciences Receives a Notice of Allowance from the U.S. Patent and Trademark Office for its Lead Investigational Drug Currently in Two Phase 2 Studies
Aug 17, 2026
Closed $6.49 (-8.7%) on Aug 17, 2026
Artelo Biosciences Provides Business Update and Reports 2026 Second Quarter Financial Results
Aug 13, 2026
Closed $6.83 (+3.5%) on Aug 13, 2026
New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic Efficacy — Reinforcing the Case for Artelo's Optimized ART12.11 CBD Composition
Jul 22, 2026
Closed $9.63 (-4.5%) on Jul 22, 2026
Artelo Biosciences Announces Results from a Nonclinical Osteoarthritis Study Supporting ART26.12 as a Potential First-in-Class New Therapy for Chronic Pain Conditions
Jul 16, 2026
Closed $10.26 (-0.9%) on Jul 16, 2026
Artelo Biosciences Issues Reminder to Shareholders to Vote in Advance of Annual Meeting on July 17, 2026
Jul 14, 2026
Closed $10.44 (+10.5%) on Jul 14, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 25 slides · September 2026
Investor Presentation (November 2019)
Investor deck · 27 slides · Nov 15, 2019
Investor Presentation (May 2018)
Investor deck · 28 slides · May 30, 2018
Investor Presentation (March 2018)
Investor deck · 28 slides · March 2018
Artelo Biosciences, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 26 in the last 12 months · 113 in all · newest Oct 26, 2026 · oldest 2019
- Decks
- 5 decks · latest September 2026
Where Artelo Biosciences, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ARTL · Home listing · This page | NASDAQ | United States | USD |
| BOATS:ARTL | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Artelo Biosciences, Inc.